Recombinational DNA Repair
"Recombinational DNA Repair" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Repair of DNA DAMAGE by exchange of DNA between matching sequences, usually between the allelic DNA (ALLELES) of sister chromatids.
| Descriptor ID |
D059767
|
| MeSH Number(s) |
G02.111.222.700 G05.219.700 G05.728.615.612
|
| Concept/Terms |
Recombinational DNA Repair- Recombinational DNA Repair
- DNA Repair, Recombinational
- Repair, Recombinational DNA
- Recombinational Repair of DNA
- DNA Recombinational Repair
- Homologous Recombinational Repair
- Homologous Recombinational Repairs
- Recombinational Repair, Homologous
- Repair, Homologous Recombinational
- Homologous Recombination Repair
- Recombination Repair, Homologous
- Homologous Recombination Repair of DNA
- Homologous Recombination DNA Repair
- Recombination Repair
- Repair, Recombination
|
Below are MeSH descriptors whose meaning is more general than "Recombinational DNA Repair".
Below are MeSH descriptors whose meaning is more specific than "Recombinational DNA Repair".
This graph shows the total number of publications written about "Recombinational DNA Repair" by people in this website by year, and whether "Recombinational DNA Repair" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recombinational DNA Repair" by people in Profiles.
-
Niraparib plus abiraterone acetate with prednisone in patients with?metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the?randomized phase III MAGNITUDE trial. Ann Oncol. 2023 09; 34(9):772-782.
-
Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice. Sci Adv. 2023 05 12; 9(19):eade0059.
-
Stellettin B Sensitizes Glioblastoma to DNA-Damaging Treatments by Suppressing PI3K-Mediated Homologous Recombination Repair. Adv Sci (Weinh). 2023 01; 10(3):e2205529.
-
SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers. J Clin Invest. 2022 06 01; 132(11).
-
MRNIP condensates promote DNA double-strand break sensing and end resection. Nat Commun. 2022 05 12; 13(1):2638.
-
Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study. Gynecol Oncol. 2022 02; 164(2):245-253.
-
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer. Nat Commun. 2021 09 22; 12(1):5574.
-
Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A review. Gynecol Oncol. 2021 08; 162(2):482-495.
-
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G. Clin Lung Cancer. 2021 05; 22(3):187-194.e1.
-
Analysis of DNA Double-Strand Break End Resection and Single-Strand Annealing in S. pombe. Methods Mol Biol. 2021; 2153:47-57.